[27P2-am1-031S] Nalmefene, a reducing alcohol consumption drug, enhances oxLDL uptake in macrophages and aggravates atherosclerotic lesion through increasing expression of CD36 scavenger receptor.
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.